Immunic, Inc.
IMUX
$12.07
-$0.12-0.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.64% | -68.85% | 24.55% | 4.63% | -5.29% |
| Total Depreciation and Amortization | 3.03% | -21.43% | 5.00% | -6.98% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 51.42% | 179.99% | -54.97% | 87.41% | -6.73% |
| Change in Net Operating Assets | -136.89% | 736.18% | -196.26% | 711.68% | -86.27% |
| Cash from Operations | -79.17% | 10.27% | 4.27% | 18.16% | -13.01% |
| Capital Expenditure | -12,350.00% | 81.82% | 83.58% | -86.11% | 23.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -12,350.00% | 81.82% | 83.58% | -86.11% | 23.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 341,237.29% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -- | -- | -- | -- |
| Cash from Financing | -99.94% | 319,632.20% | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -108.29% | 53.61% | -1,534.48% | -78.20% | -71.02% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.42% | 971.02% | 2.62% | -149.21% | 291.94% |